ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Massachusetts General Hospital
Massachusetts General Hospital
Cedars-Sinai Medical Center
New York Medical College
St. Jude Children's Research Hospital
Duke University
EMD Serono
Columbia University
National Institutes of Health Clinical Center (CC)
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seattle Children's Hospital
University of California, San Francisco
University of Pennsylvania
Iambic Therapeutics, Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University College, London
St. Justine's Hospital
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Baylor College of Medicine
Children's Oncology Group
University of Florida
Jecho Biopharmaceuticals Co., Ltd.
Mayo Clinic
Ariceum Therapeutics GmbH
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Nationwide Children's Hospital
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
University of California, San Francisco
Hutchmed
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Boston Scientific Corporation
Pfizer